Pharmaceutical Company Licenses Drug Development Compounds From UWM Research Foundation
August 14, 2020
August 14, 2020
MILWAUKEE, Wisconsin, Aug. 14 -- The University of Wisconsin's Milwaukee Campus issued the following news release:
New Jersey-based RespireRx Pharmaceuticals Inc. has licensed a group of patented drug development compounds from the University of Wisconsin-Milwaukee Research Foundation.
The newly licensed compounds, developed by the laboratory of James Cook, act on a particular neurotransmitter receptor in the brain, which has shown promise for treatment of epilepsy and . . .
New Jersey-based RespireRx Pharmaceuticals Inc. has licensed a group of patented drug development compounds from the University of Wisconsin-Milwaukee Research Foundation.
The newly licensed compounds, developed by the laboratory of James Cook, act on a particular neurotransmitter receptor in the brain, which has shown promise for treatment of epilepsy and . . .